INSPInspire Medical Systems Inc
Earnings Recap
• Reported GAAP EPS of -$0.39 down -490.00% YoY • Reported revenue of $204.58M up 1.62% YoY • Inspire Medical Systems anticipates revenue will continue to be adversely impacted during 2026 due to ongoing coding and reimbursement uncertainty, the WISeR program, and the increasing adoption of GLP-1s in the short-term.
Bullish
Inspire Medical Systems achieved an increased gross margin of 86.5% driven by its Inspire V system sales mix and generated $12.8M in net cash from operating activities while investing in sales and marketing.
Bearish
Inspire Medical Systems faces adverse revenue impacts from coding and reimbursement uncertainty, the increasing adoption of GLP-1s, and is subject to multiple ongoing legal proceedings and a government investigation.